1. At a Glance – The Chemical That Refuses to Behave
Anupam Rasayan India Ltd is currently priced at ₹1,285, commanding a market cap of ₹14,643 crore and trading at a royal P/E of 85.1. Yes, eighty-five. The stock has doubled over the last year (100% return) and delivered 3.06% in 3 months while investors argue whether it’s a genius global specialty play or an overconfident chemistry lab experiment.
Q3 FY26 numbers?
Revenue: ₹512 crore (+31% YoY)
PAT: ₹61 crore (+12% YoY)
OPM: 25%
ROCE: 7.33%
ROE: 3.32%
Debt: ₹1,223 crore
Promoter Holding: 59.07% (with 16% pledged)
On paper, growth looks shiny. On valuation, it looks expensive. On balance sheet, it looks stretched. On ambition? It looks global.
This is not a simple chemical manufacturer. This is a fluorination-heavy, US-acquisition-hunting, ECB-borrowing, pipeline-touting specialty chemical machine trying to go global.
The question is — are you paying for tomorrow’s potential or yesterday’s story?
Let’s dissect.
2. Introduction – From Surat to the United States
Anupam Rasayan started as a specialty chemical manufacturer in Gujarat. Simple enough.
But today?
It talks about:
- US acquisitions
- Fluorination platforms
- Pharma KSM import substitution
- Advanced materials
- Electronics chemicals
- EV ecosystem
- Green energy investments
This is no longer just an agro intermediate supplier.
The company operates 6 manufacturing facilities in Gujarat, capacity of ~27,000 MT, utilization at 70–75%. It serves 75 customers including 31 MNCs, with top 10 contributing 77% of revenue.
Yes. Customer concentration is real.
But entry barriers are also real — management claims 12–24 months to acquire a client. That’s sticky.
Now, Q3 FY26 shows improvement after industry normalization in agro. Pharma and Performance Materials are growing faster than legacy agro.
But here’s the tension:
- Growth is back
- Working capital is heavy
- Debt has increased
- ROE is low
- Valuation is premium
Are we looking at a compounding machine in early stage — or an over-engineered balance sheet?
Keep reading.
3.